Atenolol Export Market Intelligence: India's 300 Suppliers Shipping to 124 Countries — TransData Nexus 2026

Q: Who are the top atenolol exporters from India?

The top atenolol exporters from India are: 1. IPCA LABORATORIES LIMITED — $8.3M (20.5% market share); 2. UNICHEM LABORATORIES LIMITED — $4.8M (11.9% market share); 3. AUROBINDO PHARMA LTD — $4.1M (10.0% market share); 4. ZYDUS LIFESCIENCES LIMITED — $3.8M (9.4% market share); 5. J B CHEMICALS AND PHARMACEUTICALS LIMITED — $3.4M (8.5% market share). Together they account for 60.2% of India's total atenolol export value.

Q: What is the total export value of atenolol from India?

The total export value of atenolol from India is $40.6M USD, recorded across 3,681 shipment transactions from 300 active exporters to 124 destination countries. The average shipment value is $11.0K.

Q: Which countries import atenolol from India?

India exports atenolol to 124 countries worldwide. The top importing countries are: UNITED STATES (39.1% share, $15.9M), ZIMBABWE (10.5% share, $4.3M), FRANCE (8.8% share, $3.6M), SOUTH AFRICA (6.1% share, $2.5M), NETHERLANDS (4.9% share, $2.0M). These five markets account for 69.3% of total export value.

Q: What is the HS code for atenolol exports from India?

The primary HS code for atenolol exports from India is 30049074. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of atenolol exports from India?

The average unit price for atenolol exports from India is $6.96 USD per unit, with prices ranging from $0.00 to $2821.89 depending on formulation, packaging, and order volume. The total market is valued at $40.6M across 3,681 shipments.

Q: Which ports handle atenolol exports from India?

The primary ports for atenolol exports from India are SAHAR AIR CARGO ACC (INBOM4) (12.1% of shipments), NHAVA SHEVA SEA (INNSA1) (10.7% of shipments), SAHAR AIR (10.3% of shipments), MUNDRA SEA (6.7% of shipments), JNPT/ NHAVA SHEVA SEA (6.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of atenolol?

India is one of the world's leading exporters of atenolol due to its large base of 300 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports atenolol to 124 countries, demonstrating 64% global market coverage.

Q: What certifications do Indian atenolol exporters need?

Indian atenolol exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import atenolol from India?

There are 671 registered buyers importing atenolol from India, spread across 124 countries. The repeat buyer rate is 57.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top atenolol supplier from India?

IPCA LABORATORIES LIMITED is the leading atenolol exporter from India with a market share of 20.5% and total export value of $8.3M across 315 shipments. The top 5 suppliers together control 60.2% of total export value.

Suresh Sormare

Atenolol

India Pharmaceutical Trade Intelligence

$40.6M300 Suppliers124 CountriesHS 30049074

ExportsIndia → UNITED STATES39.1%India → ZIMBABWE10.5%

ImportsGERMANY → India$151.9K UNITED STATES → India$7.3K

#1 Supplier: IPCA LABORATORIES #1 Buyer: PHARMACEUTICAL &

Atenolol Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Atenolol to the World

Between 2022 and 2026, India exported $40.6M worth of atenolol across 3,681 verified shipments to 124 countries — covering 64% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (39.1%). IPCA LABORATORIES LIMITED leads with a 20.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049074

Atenolol export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Atenolol export data snapshot — $40.6M · 300 exporters · 124 countriesTransData Nexus · Indian Customs Data

Top Atenolol Exporters from India

300 active exporters · Ranked by export value

View all 300 →

Top Atenolol Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	IPCA LABORATORIES LIMITED	$8.3M	315	18	20.5%
2	UNICHEM LABORATORIES LIMITED

Top Countries Importing Atenolol from India

124 destination markets · Ranked by import value

All 124 countries →

Top Countries Importing Atenolol from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$15.9M	39.1%
2	ZIMBABWE	$4.3M	10.5%
3	FRANCE	$3.6M	8.8%
4	SOUTH AFRICA	$2.5M	6.1%
5	NETHERLANDS	$2.0M	4.9%
6	TANZANIA	$1.6M	4.0%
7	AUSTRALIA	$1.3M	3.1%
8	LIBERIA	$911.0K	2.2%
9	CHILE	$906.2K	2.2%
10	UNITED KINGDOM	$900.9K	2.2%

UNITED STATES is India's largest atenolol export destination, absorbing 39.1% of total exports worth $15.9M. The top 5 importing countries — UNITED STATES, ZIMBABWE, FRANCE, SOUTH AFRICA, NETHERLANDS — together account for 69.3% of India's total atenolol export value. The remaining 119 destination countries collectively receive the other 30.7%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Atenolol to India?

10 origin countries · Total import value: $163.9K

India imports atenolol from 10 countries with a combined import value of $163.9K. The largest supplier is GERMANY ($151.9K, 42 shipments), followed by UNITED STATES and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Atenolol to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$151.9K	42	92.7%
2	UNITED STATES	$7.3K	96	4.5%
3	CANADA	$1.4K	21	0.9%
4	PORTUGAL	$1.3K	2	0.8%
5	NETHERLANDS	$1.0K	4	0.6%
6	CZECH REPUBLIC	$772	5	0.5%
7	MALTA	$118	4	0.1%
8	BRAZIL	$30	2	0.0%
9	CROATIA	$18	1	0.0%
10	SWITZERLAND	$5	4	0.0%

GERMANY is the largest supplier of atenolol to India, accounting for 92.7% of total import value. The top 5 origin countries — GERMANY, UNITED STATES, CANADA, PORTUGAL, NETHERLANDS — together supply 99.4% of India's atenolol imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Atenolol

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Atenolol, a beta-blocker used primarily for treating hypertension and angina, has been available in the United States since its initial approval. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for atenolol, indicating a well-established generic market. Notably, Martec Pharmaceuticals, Inc. received approval for ANDA 74-404 on May 14, 1998, for atenolol and chlorthalidone tablets.

As of March 2026, there are no active FDA import alerts specifically targeting atenolol products from India. However, Import Alert 66-66, issued on October 22, 2024, addresses concerns about active pharmaceutical ingredients (APIs) that may be misbranded due to labeling deficiencies. While this alert does not explicitly mention atenolol, it underscores the importance of compliance with FDA labeling requirements for all APIs imported into the U.S.

India's significant role in supplying atenolol to the U.S. market is evident, with 300 active Indian exporters contributing to 39.1% of India's atenolol exports destined for the United States. This substantial market share highlights the critical need for these exporters to adhere strictly to FDA regulations to maintain uninterrupted market access.

2EU & UK Regulatory Framework

In the European Union, atenolol is subject to national marketing authorizations, as it predates the centralized approval system managed by the European Medicines Agency (EMA). Periodic safety update reports (PSURs) are conducted to monitor the drug's safety profile. For instance, the EMA published the PSUSA/00000259/202502 assessment for atenolol on November 26, 2025, resulting in variations to product information to enhance patient safety. (ema.europa.eu)

The United Kingdom, following its departure from the EU, continues to regulate atenolol through the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA aligns with EU standards, ensuring that atenolol products meet stringent safety and efficacy requirements.

Compliance with Good Manufacturing Practice (GMP) standards is mandatory for all pharmaceutical products in the EU and UK. Indian exporters must ensure their manufacturing facilities are GMP-certified to maintain access to these markets.

3WHO Essential Medicines & Global Standards

Atenolol is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards is crucial for ensuring product quality and facilitating international trade.

4India Regulatory Classification

In India, atenolol is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including atenolol, to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of atenolol formulations, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Atenolol's primary patents have long expired, leading to a competitive generic market. This expiration has facilitated the entry of multiple manufacturers, including Indian exporters, into global markets.

6Recent Industry Developments

In November 2025, the EMA published the PSUSA/00000259/202502 assessment for atenolol, resulting in variations to product information to enhance patient safety. (ema.europa.eu)

In October 2024, the FDA issued Import Alert 66-66, addressing concerns about APIs that may be misbranded due to labeling deficiencies. While not specific to atenolol, this alert emphasizes the importance of compliance with FDA labeling requirements for all APIs imported into the U.S.

These developments highlight the dynamic nature of the regulatory landscape for atenolol and underscore the necessity for exporters to stay informed and compliant with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Atenolol

Retail & reference prices across 9 markets vs. India FOB export price of $6.96/unit

Global Price Benchmark for Atenolol across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.15	USD	According to the FDA's Orange Book, atenolol is available as a generic medication, contributing to its affordability.
United Kingdom	$0.07	GBP	The NHS Drug Tariff lists atenolol as a low-cost generic medication, ensuring its widespread availability.
Germany	$0.11	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates medication pricing, maintaining atenolol's status as an affordable generic.
Australia	$0.14

Supply Chain Risk Assessment — Atenolol

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of atenolol, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70-80% of India's API and KSM requirements are sourced from China, underscoring a significant dependency on Chinese suppliers. This reliance exposes the supply chain to vulnerabilities stemming from China's regulatory changes, environmental policies, and geopolitical tensions.

In recent years, environmental crackdowns in China have led to the shutdown of several chemical manufacturing units, causing disruptions in the supply of essential raw materials. For instance, in 2018, the closure of Chinese companies due to environmental non-compliance adversely affected Indian pharmaceutical manufacturers, leading to increased costs and supply chain uncertainties. Such events highlight the risks associated with over-reliance on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

The export market for atenolol from India is notably concentrated among a few key players. The top five exporters—IPCA Laboratories Limited, Unichem Laboratories Limited, Aurobindo Pharma Ltd, Zydus Lifesciences Limited, and J B Chemicals and Pharmaceuticals Limited—collectively account for 60.2% of the total export value. IPCA Laboratories Limited alone holds a 20.5% share, amounting to $8.3 million USD. This high level of supplier concentration poses a single-source risk, where disruptions affecting any of these major exporters could significantly impact the global supply of atenolol.

Access Complete Atenolol Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,681 transactions across 124 markets.

Request Demo View Pricing

Frequently Asked Questions — Atenolol Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top atenolol exporters from India?

The leading atenolol exporters from India are IPCA LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, AUROBINDO PHARMA LTD, and 12 others. IPCA LABORATORIES LIMITED leads with 20.5% market share ($8.3M). The top 5 suppliers together control 60.2% of total export value.

What is the total export value of atenolol from India?

The total export value of atenolol from India is $40.6M, recorded across 3,681 shipments from 300 active exporters to 124 countries. The average shipment value is $11.0K.

Which countries import atenolol from India?

India exports atenolol to 124 countries. The top importing countries are UNITED STATES (39.1%), ZIMBABWE (10.5%), FRANCE (8.8%), SOUTH AFRICA (6.1%), NETHERLANDS (4.9%), which together account for 69.3% of total export value.

What is the HS code for atenolol exports from India?

The primary HS code for atenolol exports from India is 30049074. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Atenolol

Atenolol

Top Atenolol Exporters from India

Top Countries Importing Atenolol from India

Who Supplies Atenolol to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Atenolol

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Atenolol

Supply Chain Risk Assessment — Atenolol

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Atenolol Trade Intelligence

Frequently Asked Questions — Atenolol Exports from India

Who are the top atenolol exporters from India?

What is the total export value of atenolol from India?

Which countries import atenolol from India?

What is the HS code for atenolol exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of atenolol exports from India?

Which ports handle atenolol exports from India?

Why is India a leading exporter of atenolol?

What certifications do Indian atenolol exporters need?

How many buyers import atenolol from India?

What is the market share of the top atenolol exporter from India?

Analysis Methodology